Ronald B. Moss

1.3k total citations
36 papers, 1000 citations indexed

About

Ronald B. Moss is a scholar working on Epidemiology, Virology and Immunology. According to data from OpenAlex, Ronald B. Moss has authored 36 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 11 papers in Virology and 11 papers in Immunology. Recurrent topics in Ronald B. Moss's work include HIV Research and Treatment (11 papers), Influenza Virus Research Studies (9 papers) and Respiratory viral infections research (9 papers). Ronald B. Moss is often cited by papers focused on HIV Research and Treatment (11 papers), Influenza Virus Research Studies (9 papers) and Respiratory viral infections research (9 papers). Ronald B. Moss collaborates with scholars based in United States, Canada and Hong Kong. Ronald B. Moss's co-authors include Aristo Vojdani, Dennis J. Carlo, Kenneth L. Rosenthal, John M. Nicholls, Holden T. Maecker, Maria Suni, Vernon C. Maino, Susan B. Wormsley, Smita Ghanekar and Louis J. Picker and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Ronald B. Moss

35 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald B. Moss United States 17 414 413 254 205 166 36 1000
Linda L. Baum United States 20 282 0.7× 757 1.8× 196 0.8× 400 2.0× 180 1.1× 37 1.3k
Lilian Walther–Jallow Sweden 16 261 0.6× 391 0.9× 174 0.7× 397 1.9× 174 1.0× 39 1.1k
Bittoo Kanwar United States 17 533 1.3× 673 1.6× 398 1.6× 630 3.1× 348 2.1× 31 1.8k
Arthur Löve Iceland 20 633 1.5× 146 0.4× 219 0.9× 59 0.3× 131 0.8× 67 1.1k
John D. Kriesel United States 20 551 1.3× 217 0.5× 211 0.8× 81 0.4× 111 0.7× 37 949
Helen G. Durkin United States 21 232 0.6× 504 1.2× 151 0.6× 86 0.4× 154 0.9× 114 1.4k
Isabelle Garrigue France 24 925 2.2× 501 1.2× 435 1.7× 381 1.9× 137 0.8× 56 1.7k
Lara Doyle‐Meyers United States 16 230 0.6× 301 0.7× 471 1.9× 146 0.7× 140 0.8× 45 959
Mathieu Dubé Canada 18 327 0.8× 429 1.0× 994 3.9× 661 3.2× 289 1.7× 30 2.1k
Nicola F. Fletcher Ireland 17 380 0.9× 103 0.2× 266 1.0× 78 0.4× 183 1.1× 37 1.1k

Countries citing papers authored by Ronald B. Moss

Since Specialization
Citations

This map shows the geographic impact of Ronald B. Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald B. Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald B. Moss more than expected).

Fields of papers citing papers by Ronald B. Moss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald B. Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald B. Moss. The network helps show where Ronald B. Moss may publish in the future.

Co-authorship network of co-authors of Ronald B. Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald B. Moss. A scholar is included among the top collaborators of Ronald B. Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald B. Moss. Ronald B. Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moss, Ronald B., Sheeba J. Sujit, Paul Tonks, et al.. (2025). Development of Pan-H5 Vaccines Against Avian Influenza Developed Using Computational Biology to Mitigate Future Pandemics. Journal of Allergy and Clinical Immunology. 155(2). AB448–AB448.
2.
Moss, Ronald B.. (2015). DAS181: A novel host directed approach to prevent and treat virus infections. Journal of Antivirals & Antiretrovirals. 1 indexed citations
3.
Cushing, Anna M., Amanda Kamali, Mark A. Winters, et al.. (2015). Emergence of Hemagglutinin Mutations During the Course of Influenza Infection. Scientific Reports. 5(1). 16178–16178. 10 indexed citations
4.
Waghmare, Alpana, Thor A. Wagner, Robert T. Andrews, et al.. (2014). Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children. Journal of the Pediatric Infectious Diseases Society. 4(2). 114–118. 34 indexed citations
5.
Nicholls, John M., Ronald B. Moss, & Stuart M. Haslam. (2013). The use of sialidase therapy for respiratory viral infections. Antiviral Research. 98(3). 401–409. 31 indexed citations
6.
Moss, Ronald B., Roy T. Steigbigel, Rebecca Sanders, & Fang Fang. (2011). Perspective: Emerging Challenges in the Treatment of Influenza and Parainfluenza in Transplant Patients. Advances in Virology. 2011. 1–8. 7 indexed citations
7.
Moss, Ronald B.. (2009). Prospects for control of emerging infectious diseases with plasmid DNA vaccines. PubMed. 7(1). 3–3. 27 indexed citations
8.
Moss, Ronald B., et al.. (2004). Th1/Th2 cells in inflammatory disease states: therapeutic implications. Expert Opinion on Biological Therapy. 4(12). 1887–1896. 72 indexed citations
9.
Valdez, Hernán, Ronald T. Mitsuyasu, Alan Landay, et al.. (2003). Interleukin‐2 Increases CD4+Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s. The Journal of Infectious Diseases. 187(2). 320–325. 43 indexed citations
10.
Khanna, Melissa Li, Cynthia Behling, et al.. (2003). Non‐viral human IL‐10 gene expression reduces acute rejection in heterotopic auxiliary liver transplantation in rats. Microsurgery. 23(5). 432–436. 11 indexed citations
14.
Sei, Shizuko, Georgia Theofan, Silvia Ratto‐Kim, et al.. (1999). Preliminary Evaluation of Human Immunodeficiency Virus Type 1 (HIV‐1) Immunogen in Children with HIV‐1 Infection. The Journal of Infectious Diseases. 180(3). 626–640. 11 indexed citations
15.
Moss, Ronald B., et al.. (1999). TNF-α and Chronic Fatigue Syndrome. Journal of Clinical Immunology. 19(5). 314–316. 106 indexed citations
16.
Churdboonchart, Vina, Ronald B. Moss, Worachart Sirawaraporn, et al.. (1998). Safety and immunogenicity of REMUNE™ in HIV-infected Thai subjects. Vaccine. 16(2-3). 142–149. 14 indexed citations
18.
Ferré, F., Ronald B. Moss, Anne E. Daigle, et al.. (1996). Combination Therapies Against HIV-1 Infection: Exploring the Concept of Combining Antiretroviral Drug Treatments with HIV-1 Immune-Based Therapies in Asymptomatic Individuals. . .. AIDS Patient Care and STDs. 10(6). 357–361. 3 indexed citations
19.
Moss, Ronald B. & Marc G. Golightly. (1991). In vitro enhancement of natural cytotoxicity by a trial natriuretic peptide fragment 4–28. Peptides. 12(4). 851–854. 19 indexed citations
20.
Moss, Ronald B., Howard B. Moss, & Jordan B. Peterson. (1989). Microstress, Mood, and Natural Killer-Cell Activity. Psychosomatics. 30(3). 279–283. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026